LSMA welcomes the European Commission’s initiative to develop a comprehensive European Strategy on Research and Technology Infrastructures. LSMA is a coalition of leading Life Sciences manufacturers providing critical products and services used in the development and production of innovative products, such as human and animal health products, including vaccines, diagnostic tests, and life-saving medicines.
LSMA members are key contributors to healthcare delivery and health security, including pandemic preparedness and response. They also have a pivotal role in meeting the goals of the New Industrial Strategy for Europe, which identifies Life Sciences as a sector critical to key enabling technologies.
LSMA is committed to contributing its expertise to ensure the strategy effectively addresses the needs and challenges of the European research and innovation ecosystem and strengthens Europe’s scientific and technological base.
